Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.
MONROVIA, Liberia - Liberian officials faced a difficult choice Thursday: deciding which handful of Ebola patients will receive an experimental drug that could prove life-saving, ineffective or even harmful.
ZMapp, the untested Ebola drug, arrived in the West African country late Wednesday. Assistant Health Minister Tolbert Nyenswah said three or four people would begin getting it Thursday, although another health official said there was only enough for three people.
The government had previously said two doctors would receive the treatment, but it was unclear who else would.
Three Liberian Health Workers Get Experimental Ebola Drug
By SHERI FINKAUG. 16, 2014
Three Liberian health care workers who have Ebola received an extremely scarce experimental serum on Friday at a hospital outside the national capital, Monrovia, a Liberian health official said Saturday.
Tolbert G. Nyenswah, an assistant minister of health and social welfare, would not say if any of the three were doctors...
19 August 2014 Last updated at 13:25 ET
Ebola crisis: Doctors in Liberia 'recovering after taking ZMapp'
Three doctors in Liberia with Ebola who started taking an experimental drug last Thursday are showing remarkable signs of improvement, a minister says...